Brain zaps to beat addiction? VA tests rTMS for stimulant relapse
NCT ID NCT07112105
First seen Apr 05, 2026 · Last updated Jun 22, 2026 · Updated 11 times
Summary
This study tests whether repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, can help veterans with severe stimulant use disorder avoid relapse. Over 2 weeks, 106 participants will receive either real or sham rTMS, and researchers will track relapse rates and brain changes using fMRI. There is currently no FDA-approved treatment for this condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STIMULANT USE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, 94304-1207, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
repetitive transcranial magnetic stimulation (rTMS)
What this could lead to
If it works, this could provide a new, non-invasive treatment option for stimulant use disorder, helping people avoid relapse.
What could go wrong
This is an early-stage trial with only 106 participants, so results may not apply to everyone. The sham control group helps test effectiveness, but the treatment may not prove better than placebo.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.